SciClone Pharmaceuticals
SciClone profit up 4.3% to RMB622.7m in H1 2021
SciClone profit up 4.3% to RMB622.7m in H1 2021
Its revenue rose 14.7% to RMB1.3b in the same period.
Most Read
1. WA Health expands digital messaging to boost emergency response 2. Medical devices supply chains at risk as China tightens rare earth exports 3. NHG Health appoints Joe Hau as new Woodlands Health CEO 4. Australia’s Victoria to launch virtual hospital pilot 5. HMI Medical, Ibraco ink land deal for new Kuching HospitalResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Partner Events
Nov
12
Event News
Be recognised as one of the region’s most exceptional healthcare providers and innovators.
